1. U.S. Food and Drug Administration. Guidance for industry and reviewers: estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. Available at: http://www.fda.gov/CbER/gdlns/dose.pdf. Accessed January 16, 2003.
2. Expert group on phase one clinical trials: final report,2006
3. European Medicines Agency. Guideline on strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products. Available at: http://www.emea.europa.eu/pdfs/human/swp/2836707enfin.pdf. Accessed July 19, 2007.
4. TGN1412—a regulator's perspective;Schneider;Nat Biotechnol,2006
5. European Medicines Agency. CHMP Position paper on non-clinical safety studies to support clinical trials with a single microdose. Available at: http://www.emea.europa.eu/pdfs/human/swp/259902en.pdf. Accessed June 23, 2004.